Related Experiment Video
Updated: Aug 8, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression
Gopeshwar Narayan1, Chandra Goparaju, Hugo Arias-Pulido
1Department of Pathology, College of Physicians & Surgeons of Columbia University, New York, NY, USA. gn110@columbia.edu
Background:
Cervical Cancer (CC) exhibits highly complex genomic alterations. These include hemizygous deletions at 4p15.3, 10q24, 5q35, 3p12.3, and 11q24, the chromosomal sites of Slit-Robo pathway genes. However, no candidate tumor suppressor genes at these regions have been identified so far. Slit family of secreted proteins modulates chemokine-induced cell migration of distinct somatic cell types. Slit genes mediate their effect by binding to its receptor Roundabout (Robo). These genes have shown to be inactivated by promoter hypermethylation in a number of human cancers.
Results:
To test whether Slit-Robo pathway genes are targets of inactivation at these sites of deletion, we examined promoter hypermethylation of SLIT1, SLIT2, SLIT3, ROBO1, and ROBO3 genes in invasive CC and its precursor lesions. We identified a high frequency of promoter hypermethylation in all the Slit-Robo genes resulting in down regulated gene expression in invasive CC, but the inhibitors of DNA methylation and histone deacetylases (HDACs) in CC cell lines failed to effectively reactivate the down-regulated expression. These results suggest a complex mechanism of inactivation in the Slit-Robo pathway in CC. By analysis of cervical precancerous lesions, we further show that promoter hypermethylation of Slit-Robo pathway occurs early in tumor progression.
Conclusion:
Taken together, these findings suggest that epigenetic alterations of Slit-Robo pathway genes (i) play a role in CC development, (ii) further delineation of molecular basis of promoter methylation-mediated gene regulation provides a potential basis for epigenetic-based therapy in advanced stage CC, and (iii) form epigenetic signatures to identify precancerous lesions at risk to progression.
Insights
Epigenetic silencing of Slit-Robo pathway genes via promoter hypermethylation is common in cervical cancer (CC) development. These alterations occur early in precancerous lesions, suggesting potential for epigenetic signatures and therapies.
Area of Science:
- Genomics
- Epigenetics
- Cancer Biology
Background:
- Cervical cancer (CC) features complex genomic alterations, including deletions at chromosomal sites of Slit-Robo pathway genes.
- Slit-Robo pathway genes are crucial for cell migration and have been implicated in various cancers through promoter hypermethylation.
- No specific tumor suppressor genes at these deletion sites have been identified previously.
Purpose of the Study:
- To investigate if Slit-Robo pathway genes are inactivated by promoter hypermethylation in cervical cancer.
- To determine the role of these epigenetic alterations in CC development and progression.
- To explore the potential for epigenetic signatures and therapies in CC.
Main Methods:
- Examined promoter hypermethylation of SLIT1, SLIT2, SLIT3, ROBO1, and ROBO3 genes in invasive CC and precursor lesions.
- Assessed gene expression changes associated with hypermethylation.
- Utilized inhibitors of DNA methylation and histone deacetylases (HDACs) in CC cell lines to test for reactivation of gene expression.
Main Results:
- Identified high-frequency promoter hypermethylation in all tested Slit-Robo genes in invasive CC, leading to downregulated gene expression.
- Inhibitors of DNA methylation and HDACs showed limited success in reactivating gene expression, indicating complex inactivation mechanisms.
- Promoter hypermethylation of Slit-Robo pathway genes was found to occur early in cervical tumor progression.
Conclusions:
- Epigenetic alterations, specifically promoter hypermethylation, of Slit-Robo pathway genes play a significant role in cervical cancer development.
- Understanding the molecular basis of methylation-mediated gene regulation offers potential for developing epigenetic-based therapies for advanced CC.
- Epigenetic signatures derived from these alterations could aid in identifying precancerous lesions at risk of progression.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MicroRNAs
MicroRNAs
